Literature DB >> 10998328

Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells.

S Duhaut1, N J Dimmock.   

Abstract

Defective influenza A virus RNAs analyzed in two studies so far possess at least 80-90 nucleotides from the 5' end of the virion RNA segment and more typically around 200 nucleotides, whereas the 3' sequence could be as short as 25 nucleotides (P. A. Jennings et al., Cell 34, 619-627; 1983; S. D. Duhaut and N. J. Dimmock, Virology 247, 241-253, 1998). To determine the biological significance of the highly conserved 5' sequence, we constructed plasmids that expressed a naturally occurring defective segment 1 RNA from A/equine/Newmarket/7339/79 (EQV, H3N8) or modified RNAs with lesser amounts of the 5' end. These had terminal 5' sequences of 220 nucleotides (POLI-220), 150 nucleotides (POLI-150), 80 nucleotides (POLI-80), and 30 nucleotides (POLI-30). Their remaining sequence came from the 3' end of virion RNA, and all were exactly 445 nucleotides in length. After transfection with one of the RNA-expressing POLI plasmids and plasmids encoding PB1, PB2, PA, and NP proteins, Vero cells were infected with a helper influenza virus of one of three different subtypes (the parental H3N8, an H2N2, or an H1N1 virus). Progeny infectious and presumptive progeny defective virus in the resulting tissue culture fluids were then passaged serially to new cultures up to 10 times. We found that POLI-220 and POLI-150 RNAs proved stable on passage and POLI-80 RNA was detected intermittently, while POLI-30 was not detected beyond passage three. Data were essentially reproducible with the three helper viruses and in two cell lines. It thus appears that the terminal 5' 150 nucleotides are necessary for influenza virion RNA molecules to be replicated and packaged consistently in cell culture. The possible functional significance of the 5' sequence is discussed. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998328     DOI: 10.1006/viro.2000.0502

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions.

Authors:  Yukiko Muramoto; Ayato Takada; Ken Fujii; Takeshi Noda; Kiyoko Iwatsuki-Horimoto; Shinji Watanabe; Taisuke Horimoto; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

2.  Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.

Authors:  Edward C Hutchinson; Martin D Curran; Eliot K Read; Julia R Gog; Paul Digard
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

Review 3.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

4.  Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA.

Authors:  Bo Meng; Kirsten Bentley; Anthony C Marriott; Paul D Scott; Nigel J Dimmock; Andrew J Easton
Journal:  Virol J       Date:  2017-07-24       Impact factor: 4.099

5.  Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus.

Authors:  Kazima Saira; Xudong Lin; Jay V DePasse; Rebecca Halpin; Alan Twaddle; Timothy Stockwell; Brian Angus; Alessandro Cozzi-Lepri; Marina Delfino; Vivien Dugan; Dominic E Dwyer; Matthew Freiberg; Andrzej Horban; Marcelo Losso; Ruth Lynfield; Deborah N Wentworth; Edward C Holmes; Richard Davey; David E Wentworth; Elodie Ghedin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

6.  Evidence for segment-nonspecific packaging of the influenza a virus genome.

Authors:  Christa T Bancroft; Tristram G Parslow
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.

Authors:  Paul D Scott; Bo Meng; Anthony C Marriott; Andrew J Easton; Nigel J Dimmock
Journal:  Vaccine       Date:  2011-07-14       Impact factor: 3.641

8.  Codon conservation in the influenza A virus genome defines RNA packaging signals.

Authors:  Julia R Gog; Emmanuel Dos Santos Afonso; Rosa M Dalton; India Leclercq; Laurence Tiley; Debra Elton; Johann C von Kirchbach; Nadia Naffakh; Nicolas Escriou; Paul Digard
Journal:  Nucleic Acids Res       Date:  2007-03-01       Impact factor: 16.971

9.  Characterisation of influenza A viruses with mutations in segment 5 packaging signals.

Authors:  Edward C Hutchinson; Helen M Wise; Katerine Kudryavtseva; Martin D Curran; Paul Digard
Journal:  Vaccine       Date:  2009-10-23       Impact factor: 3.641

10.  Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.

Authors:  Nigel J Dimmock; Brian K Dove; Bo Meng; Paul D Scott; Irene Taylor; Linda Cheung; Bassam Hallis; Anthony C Marriott; Miles W Carroll; Andrew J Easton
Journal:  Antiviral Res       Date:  2012-10-04       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.